Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Triple-negative Breast Cancer
Clinical trial NCT06798506 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06798506
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-02-15
- Primary completion
- 2027-01-15
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.